Navigation Links
JMIR Article by IHLS Authors Discusses Global Public Health Implications of Social Media Direct-to-Consumer Advertising by Illicit Online Pharmacies and Private Entities

SAN DIEGO, Sept. 6, 2011 /PRNewswire/ -- In a article published in the August issue of the Journal of Medical Internet Research (JMIR), Dr. Bryan A. Liang, Shapiro Distinguished Professor of Health Law & Executive Director, Institute of Health Law Studies (IHLS), California Western School of Law (CWSL); and Mr. Tim Mackey, Senior Research Associate at IHLS and PhD Student in the Global Health Program at University of California, San Diego – San Diego State University, assess the global public health and patient safety implications of unregulated social media Direct-to-Consumer Advertising using web 2.0 (eDTCA 2.0) by online pharmacies and pharmaceutical corporations.


eDTCA 2.0 pharmaceutical marketing has emerged with the rapid utilization of social media by healthcare consumers.  Popular social media sites such as Facebook, Twitter, YouTube, and blogs are now advertising healthcare products directly to consumers.  In their study, Dr. Liang and Mr. Mackey report that the use of eDTCA 2.0 by pharmaceutical corporations is widespread and common with all of the top 10 global pharmaceutical companies having a presence on Facebook, Twitter/Friendster, sponsored blogs and RSS feeds.

In the first documented work of this phenomena, Liang and Mackey's findings also report that illicit online pharmacies selling dangerous drugs over the Internet without a prescription are also utilizing eDTCA 2.0, raising serious health risks for patients. Alarmingly, of the Top 10 grossing drugs in 2009, 90% (9/10) are marketed via eDTCA 2.0 by these illicit actors. Further, 16/20 of the world's top marketed drugs are also sold through these illegal actors in social media forums. Facebook alone had 60% of the top 10 grossing drugs and 50% of the world's 20 most marketed drugs being advertised illicitly.

In order to address this global health and patient safety issue, Liang and Mackey call for greater surveillance, transparency and regulation of illegal eDTCA 2.0 export by the government, marketers, pharmaceutical manufacturers and various Internet service providers.

The research article is entitled, "Prevalence and Global Health Implications of Social Media in Direct-to-Consumer Advertising" and is available online free of charge as an open access piece at  JMIR is the world's top ranked journal for health informatics and second in health sciences & health services research categories.

About the Institute of Health Law Studies

The Institute of Health Law Studies is a Center of Excellence of the California Western School of Law, and is dedicated to the interdisciplinary study of complex health policy issues.  IHLS engages in research, advocacy, community service, and education, to fulfill its mission of "Improving health care today … for all our tomorrows."

Further information can be obtained by contacting media contact Pam Tait at or at (619) 515-1569.  For more information visit the IHLS Web site at  

SOURCE Institute of Health Law Studies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
2. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
3. Tumor Eradication Article Published by Cancer Research
4. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
5. Clinical Trial Participation Unaffected by Disclosure of Investigators Financial Stake, Food and Drug Law Journal Article Finds
6. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
7. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
8. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
9. Particle Sciences Expands Its Combination Product Capabilities
10. InVitrias Cellastim Showcased in Nature Article
11. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
Post Your Comments:
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology:
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
Breaking Medicine News(10 mins):